Spinal Muscular Atrophy Drug Development Announced
Families of SMA announced recently the selection of a clinical candidate for spinal muscular atrophy through its program being conducted at deCODE chemistry. The lead compounds have shown the ability to extend survival in a mouse model of SMA.
For more information on this announcement, you can read the news release from FSMA.
Tags: research, sma, spinal muscular atrophy, treatmentShare This Post Via Email or Social Bookmark:


